Key Opinion Leaders and independent oversight committee members are rarely dedicated to a single trial. A respected clinician or statistician who serves as a Data Monitoring Committee member or a scientific advisor typically holds several such roles at once, across different sponsors and different trials, alongside a full clinical or academic career. That fact changes what actually drives whether they stay engaged with a given trial. It is not simply a question of how much work the role involves, the way it might be for someone whose full-time job is that one trial. It is a question of how much of that work is spent relearning a process that looks nothing like the one they just used for a different sponsor’s committee the week before.
The Cost Is Switching, Not Just Volume
A trial manager or coordinator dedicated to one study experiences administrative burden as a share of their week: too much of it goes to coordination, not enough to judgment. A KOL or independent committee member experiences something more specific: every trial they serve asks them to learn a new set of conventions, where documents live, how meetings get scheduled, what format materials arrive in, before they can do the substantive work they were brought on for. Multiply that across several concurrent engagements, and the friction is not the total amount of work; it is the tax paid every time they move from one committee’s process to another’s.
That switching cost is easy to underestimate because it does not show up as a single frustrating task. It shows up as a low-grade drag on every engagement, a few extra minutes here, a missed update there, that makes the overall experience of serving on a given trial feel more effortful than the substantive work alone would justify.
Bespoke Processes Are a Hidden Cost of Doing Things “Our Way”
It is natural for a sponsor to want its trial run its own way, and there are good reasons for a sponsor’s internal process to be specific to its own needs. The cost of that specificity falls disproportionately on the people serving across multiple sponsors, because each bespoke process is one more thing to learn and remember correctly. An expert who has to keep straight which sponsor uses which document format, which committee expects updates on which schedule, and which platform requires which login is carrying a real cognitive load that has nothing to do with their clinical or statistical judgment.
A process that looks familiar from one engagement to the next removes that load without asking any sponsor to give up what makes its trial distinct in substance. The structure of how a review happens, how materials are organized, how a decision gets documented, can be consistent even when the protocol, the therapeutic area, and the committee’s substantive judgment are not.
Onboarding an Expert Is Not Free, Even When They Say Yes
The cost of an unfamiliar process does not stop at the expert’s own frustration. Every time a KOL or independent committee member has to be walked through a sponsor-specific way of working, someone on the trial’s staff spends time doing that walkthrough, and the expert spends the first stretch of the engagement operating below their normal effectiveness while they get oriented. That onboarding cost repeats for every new engagement a sponsor brings someone into, and it is easy to miss in a project plan because it looks like a normal ramp-up period rather than a cost the trial’s own process design created.
A sponsor whose process resembles what a respected expert already uses elsewhere shortens that ramp-up considerably. The expert recognizes the shape of the work on day one, which means the committee benefits from their full attention closer to the start of the engagement rather than partway through it.
What This Means for Who Stays and Who Says No Next Time
An expert deciding whether to take on another committee seat, or whether to remain engaged with one they already hold, is weighing the value of the work against everything surrounding it. A trial that asks for a disproportionate amount of relearning, relative to the actual time the substantive review takes, is a less attractive use of a scarce and much-requested person’s time than one that lets them apply the same working habits they use everywhere else. Over several concurrent commitments, that difference compounds: the trials that ask the least of an expert’s attention outside the actual clinical judgment are the ones most likely to keep that person engaged through a multi-year study.
Consistency Is a Capacity Question, Even for People Outside the Trial’s Own Staff
The Capacity pillar of a governed execution environment is usually framed around giving time back to the people running a trial day to day. The same logic extends to the outside experts a trial depends on but does not employ. A process that behaves the same way across every engagement a KOL or independent committee member holds gives them back exactly the kind of time that a bespoke, sponsor-specific workflow quietly takes away, and it does so without requiring any sponsor to standardize its trial design or its scientific approach.
Sponsors competing for the attention of a limited pool of respected experts are not only competing on the substance of their trial. They are competing on how much of an expert’s time a given engagement asks for beyond the judgment it was designed to draw on, and a familiar, consistent process is one of the few parts of that equation a sponsor fully controls.